- Recent Funding
- Investors
- Wanghui Capital
Wanghui Capital portfolio
Wanghui Capital has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Laekna Therapeutics's $61M Series B+ round in May 2022, alongside HB Ventures, Yanchuang Capital, CS Capital and 2 others. That company is in Health and bio.
What Wanghui Capital invests in
- Health and bio · 1 · 100%
How Wanghui Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $61M |
Wanghui Capital portfolio companies
LLaekna Therapeutics$61MSeries B+ · May 2022
| Company | Round with Wanghui Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $61M | $61M | May 18, 2022 Series B+ |
Most frequent co-investors
HHB Ventures1 shared round · last May 18, 2022
YYanchuang Capital1 shared round · last May 18, 2022
CCS Capital1 shared round · last May 18, 2022
IInfinity Capital1 shared round · last May 18, 2022
- CCMG-SDIC Capital Management1 shared round · last May 18, 2022
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Wanghui Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Wanghui Capital, which is a subset of its real portfolio. API: /api/v1/investors/wanghui-capital (get a free API key). More: the most active VC firms and new venture capital funds.